Those who have had damage to the upper lining of their gastrointestinal tract are 76% more likely to develop Parkinson’s disease, according to research led by Beth Israel Deaconess Medical Center.

“We are excited to enter the clinic with our lead drug APR003 that was designed utilizing our tissue-targeted chemistry to deliver a TLR7 agonist in abundance to liver and GI tissue with little ...

AUSTIN, Texas, July 07, 2025--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced data from a colorectal cancer (CRC) study of its tissue-free ...

GI Involvement in EGPA Linked to Eosinophilic Tissue Infiltration, Weight Loss. Lisa Kuhns, PhD | Publish Date March 7, 2025 March 7, 2025 ...

Synthetic coating for the GI tract could deliver drugs or aid in digestion MIT engineers devise a temporary film that may help treat diabetes, infections, and other conditions ...

The synthetic coating adhered to pig and human tissue ex vivo, remaining stable for up to 24 hours. When administered to pigs endoscopically, polydopamine solution with suspended β-galactosidase ...

In the gastrointestinal (GI) tract, this killing of normal cells can cause such side effects as nausea or diarrhea within days or weeks of treatment, and serious GI tissue damage can occur months ...